Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Nishida

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cancers|June 2, 2021
Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive ReviewHiroko Nishida
Hematology Reports|May 4, 2018
Bone-targeted agents in multiple myelomaHiroko Nishida
Journal of Oncology|November 30, 2019
Monoclonal Antibody Therapies in Multiple Myeloma: A Challenge to Develop Novel TargetsHiroko Nishida, Taketo Yamada
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 8, 2011
Primary B-cell lymphoma of the cauda equina, successfully treated with high-dose methotrexate plus high-dose cytarabine: a case report with MRI findingsHiroko Nishida, Masao Hori, Katsuyuki Obara
Leukemia Research Reports|January 1, 2019
Primary isolated bone marrow diffuse large B cell lymphoma with long-term complete remissionHiroko Nishida, Hiroshi Suzuki, Masao Hori, et al.
Leukemia Research|January 1, 2008
Isochromosome i(17q) as a sole cytogenetic abnormality in a case of leukemic transformation from myelodysplastic syndrome (MDS)/myeloproliferative diseases (MPD)Hiroko Nishida, Hironori Ueno, Jae Wong Park, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 17, 2014
Optic nerve involvement of Waldenström's macroglobulinemia: with autopsy findingsHiroko Nishida, Risa Hashida, Mami Hatano, et al.
Blood Cancer Journal|October 24, 2018
CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myelomaHiroko Nishida, Mutsumi Hayashi, Chikao Morimoto, et al.
Biochemical and Biophysical Research Communications|April 4, 2009
CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cellsHiroto Yamazaki, Hiroko Nishida, Satoshi Iwata, et al.
Biochemical and Biophysical Research Communications|November 6, 2007
Stem cell properties and the side population cells as a target for interferon-alpha in adult T-cell leukemia/lymphomaHiroyuki Kayo, Hiroto Yamazaki, Hiroko Nishida, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cancers|June 2, 2021
Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive ReviewHiroko Nishida
Hematology Reports|May 4, 2018
Bone-targeted agents in multiple myelomaHiroko Nishida
Journal of Oncology|November 30, 2019
Monoclonal Antibody Therapies in Multiple Myeloma: A Challenge to Develop Novel TargetsHiroko Nishida, Taketo Yamada
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 8, 2011
Primary B-cell lymphoma of the cauda equina, successfully treated with high-dose methotrexate plus high-dose cytarabine: a case report with MRI findingsHiroko Nishida, Masao Hori, Katsuyuki Obara
Leukemia Research Reports|January 1, 2019
Primary isolated bone marrow diffuse large B cell lymphoma with long-term complete remissionHiroko Nishida, Hiroshi Suzuki, Masao Hori, et al.
Leukemia Research|January 1, 2008
Isochromosome i(17q) as a sole cytogenetic abnormality in a case of leukemic transformation from myelodysplastic syndrome (MDS)/myeloproliferative diseases (MPD)Hiroko Nishida, Hironori Ueno, Jae Wong Park, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 17, 2014
Optic nerve involvement of Waldenström's macroglobulinemia: with autopsy findingsHiroko Nishida, Risa Hashida, Mami Hatano, et al.
Blood Cancer Journal|October 24, 2018
CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myelomaHiroko Nishida, Mutsumi Hayashi, Chikao Morimoto, et al.
Biochemical and Biophysical Research Communications|April 4, 2009
CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cellsHiroto Yamazaki, Hiroko Nishida, Satoshi Iwata, et al.
Biochemical and Biophysical Research Communications|November 6, 2007
Stem cell properties and the side population cells as a target for interferon-alpha in adult T-cell leukemia/lymphomaHiroyuki Kayo, Hiroto Yamazaki, Hiroko Nishida, et al.
Pageof 3